The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution [Corrigendum]

The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution [Corrigendum]

Wang Y, Lu M, Zhou Y, et al. Cancer Manag Res. 2020;12:5255–5264. The authors have advised that there is an error in Table 1 on page 5257. The value “26.00” in the Median row for Age(years) should read “31.5”. The authors h...

Full description

Bibliographic Details
Main Authors: Wang Y, Lu M, Zhou Y, Zhou S, Yu X, Tang F, Luo Y, Zhang W, Duan H, Min L, Tu C
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Cancer Management and Research
Subjects:
synovial sarcoma
apatinib
targeted therapy
efficacy
safety
Online Access:https://www.dovepress.com/corrigendum-the-efficacy-and-safety-of-apatinib-in-advanced-synovial-s-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/corrigendum-the-efficacy-and-safety-of-apatinib-in-advanced-synovial-s-peer-reviewed-article-CMAR

Similar Items